Skip to Content

Stamaril Side Effects

Generic Name: yellow fever vaccine

Note: This document contains side effect information about yellow fever vaccine. Some of the dosage forms listed on this page may not apply to the brand name Stamaril.

For the Consumer

Applies to yellow fever vaccine: subcutaneous injectable, subcutaneous powder for solution, subcutaneous powder for suspension

Along with its needed effects, yellow fever vaccine (the active ingredient contained in Stamaril) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking yellow fever vaccine:

  • Confusion
  • convulsions (seizures)
  • coughing
  • difficulty with breathing or swallowing
  • fast heartbeat
  • feeling of burning, crawling, or tingling of the skin
  • nervousness or irritability
  • reddening of the skin
  • severe headache
  • skin rash or itching
  • sneezing
  • stiff neck
  • throbbing in the ears
  • unusual tiredness or weakness
  • vomiting

Some side effects of yellow fever vaccine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common
  • Difficulty with moving
  • joint pain
  • low fever
  • mild headache
  • muscle aching or cramping
  • muscle pains or stiffness
  • pain at the injection site
  • swollen joints

For Healthcare Professionals

Applies to yellow fever vaccine: injectable powder for injection, subcutaneous powder for injection


Minor side effects have included mild headache, myalgia, malaise, asthenia and low-grade fever for 5 to 10 days after vaccination in < 5% to 30% of vaccinees. The incidence of minor adverse events was lower in vaccinees > 60 years than in younger subjects.[Ref]


Local side effects have included edema, erythema, hypersensitivity, pain, or mass at the injection site.[Ref]


Hypersensitivity reactions have infrequently included immediate reactions characterized by rash, urticaria, and/or asthma. These mainly occur in vaccinees with histories of egg allergy.[Ref]

Nervous system

Nervous system side effects have very rarely included neurotropic disease (YEL-AND, post-vaccinal encephalitis) which has been fatal in rare instances. Symptoms have included diaphoresis, rigors, fever, malaise, headache, confusion, expressive aphasia, arm numbness, loss of fine motor control, severe dysarthria, loss of consciousness, elevated WBCs and protein in CSF, and/or leukocytosis. Immunosuppression and age < 9 months are known risk factors. The estimated incidence for all ages is 5.3 cases per million vaccinees.[Ref]

Fifteen cases of neurotropic disease were reported before 1960, 13 of these occurred in infants < 4 months and 2 in infants 6 and 7 months old. Six cases were reported worldwide between 1960 and 1996, 3 of these occurred in adults, and the other 3 in a 1-month-old infant, a 3-year-old, and a 13-year-old. A genetic variant of the vaccine virus was isolated from the brain of the 3-year-old, who died of encephalitis.

Four nonfatal cases of probable 17D vaccine-associated neurotropic disease were reported in the U.S. between 2001 and 2002. High levels of yellow fever-specific IgM antibody were observed in these patients' CSF; however viral isolation was negative or not performed.[Ref]


Seven cases of YEL-AVD were reported between 1996 and 2001, 4 of them in U.S. residents. All patients (ages 5 to 79 years old) were considered healthy and did not have immunodeficiency. Six of these patients died 8 to 11 days after vaccination (1 had been vaccinated with the 17D-204 strain and 2 with the 17DD strain). A liver biopsy revealed rare yellow fever virus antigen within Kupffer cells. In 3 of the fatal cases, hepatic midzonal necrosis, microvesicular fatty change, and Councilman bodies were observed, which are characteristic of wild-type yellow fever. Vaccine-type yellow fever virus was isolated from blood and autopsy material.[Ref]

Vaccine-associated viscerotropic disease (YEL-AVD, multiple organ system failure), which may be fatal, has been reported rarely. It is characterized by initial symptoms of a nonspecific febrile syndrome with fatigue, myalgia, and headache. It quickly progresses to severe illness including respiratory failure, elevated hepatocellular enzymes, lymphocytopenia, thrombocytopenia, hyperbilirubinemia, hypotension with poor tissue perfusion, and/or renal failure requiring hemodialysis. Causality has not been clearly established. The syndrome may be related to unknown host factors rather than virulence of the 17D yellow fever strain. Recent reports suggest that a history of thymic dysfunction (e.g., myasthenia gravis, thymoma, thymectomy, DiGeorge syndrome) and age > 60 years may be risk factors for developing YEL-AVD. The estimated incidence is 1 per 400,000 doses.[Ref]

Health care providers should report any allergic or unusual adverse reactions to the Vaccine Adverse Event Reporting System (VAERS) at 1-800-822-7967 (USA) and the manufacturer.[Ref]


1. "Product Information. YF-Vax (yellow fever vaccine)." Connaught, Swiftwater, PA.

2. "Adverse events associated with 17D-derived yellow fever vaccination--United States, 2001-2002." Morb Mortal Wkly Rep 51 (2002): 989-993

3. CDC. Centers for Disease Control and Prevention. National Center for Infectious Diseases Travelor's Health "Yellow fever vaccine risk and updated yellow fever vaccine information statement (VIS). Available from: URL:" ([2004 Dec 3]):

4. "Fever, jaundice, and multiple organ system failure associated with 17D-derived yellow fever vaccination, 1996-2001." MMWR Morb Mortal Wkly Rep 50 (2001): 643-5

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.